Tuesday, 25 January, 2022
TopicSerum Institute of India

Topic: Serum Institute of India

Modi govt allows Serum Institute to export 50 lakh Covishield doses under COVAX to 4 nations

The SII will commence Covid vaccine export under the COVAX programme from 23 November. Nepal, Tajikistan, Mozambique and Bangladesh are the 4 nations that will receive the doses.

Serum Institute urges Modi govt to fast-track movement of increasing Covishield stock

SII's Director of Government and Regulatory Affairs is learnt to have recently communicated to Union Health Ministry that it has a manufactured stock of 24,89,15,000 Covishield doses.

Serum Institute of India gets govt nod to export 5 crore doses of Covovax to Indonesia

Covovax has been developed by Novavax and is being manufactured by the Pune-based SII, but is not cleared for emergency use in India.

Novavax’s Covid vaccine, made by Serum Institute of India, gets emergency use nod in Indonesia

Serum Institute of India, world's largest vaccine manufacturer, will market the nanoparticle protein-based vaccine in Indonesia under the brand name Covovax.

Vaccine makers upset over ‘differential pricing’ for ZyCov-D, and lack of clarity on exports

ZyCov-D has reportedly been priced by the company at Rs 1,900 for three doses while the others cost between Rs 205-215 per dose.

Biocon partners SII to make vaccine, drug manufacturing accessible to developing nations

Under the deal, Biocon Biologics Ltd (BBL) will offer approximately 15% stake to Serum Institute Life Sciences at a post-money valuation of about Rs 35,000 crore.

1 cr/day target achieved, Modi govt looks to administer 100 cr Covid vaccines in next 3 months

If projections of all four vaccine companies in India — SII, Zydus Cadila, Bharat Biotech and Biological E — are met, India is likely to acquire 100 crore more doses between October and December 2021.

Centre places order with Serum Institute of India for 66 crore Covishield doses

SII has enhanced the manufacturing capacity of Covishield to more than 20 crore doses per month, and the latest consignment ordered by Centre is to be supplied by December.

At 16.4 cr doses, SII’s increased Covishield output helps India cross Aug vaccination target

Modi govt, which projected 15 crore doses would be available in August, managed to achieve its 1 crore-doses-a-day plan last week. Meanwhile, Covaxin production lags.

Will supply 20 crore doses of Covishield in September, SII notifies Modi govt

In a production plan submitted to the Centre in May, SII’s director communicated that the production of Covishield would be ramped up to 10 crore each in August, September, said sources.

On Camera


Representative image of Army | ANI

Central Vista, old army uniforms—why this year’s Republic Day parade is a source of pride

Days of Mughal or British glory are over. Central Vista is Indian govt's modern structure, and uniforms are sources of pride.
A Chinese flag being raised in the Lujiazui Financial District of Shanghai | Photo: Qilai Shen | Bloomberg

India among Asian destinations for investors fleeing Chinese real estate debt crisis

Both Goldman Sachs & CreditSights consider Indian companies attractive. While the first recommends high-yield renewables, the latter considers financial firms to well shielded here.


File photo of Scorpene-class submarine 'INS Vela', at the Naval Dockyard in Mumbai | ANI

Kamov choppers, submarine torpedoes among deals defence ministry will review this week

Ministry is reviewing all procurement under the ‘Buy (Global)’ category, under which equipment is bought directly from foreign manufacturers, amid govt's 'Atmanirbhar' push.

Modi vs non-BJP CMs: When most popular isn’t all-powerful & why Centre-state ties will worsen

Modi’s inability to win many states, and the huge popularity his rivals enjoy there, is pushing Indian politics in a more robustly federal direction.